I see value in this stock.
Axiron sales in FY16 USD149.3m vs FY17 USD143m which is not materially different. If the patent appeal is successful, I expect sales to maintain at this level and dividends to return. If unsuccessful, we should make up some of the lost sales with our own generic product.
Cash in the Bank was 32m as at 31 Dec 2016.
I like the fact Acrux has a commercialized product generating good income to help fund the pipeline of work.
One thing I don't like about this company (which has been discussed many times) is the poor communication and updates regarding the pipeline!
- Forums
- ASX - By Stock
- Ann: Axiron Net Sales Quarter to 30 June 2017
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

I see value in this stock. Axiron sales in FY16 USD149.3m vs...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 674564 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 522500 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 674564 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 522500 | 4 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 12.30pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |